Cargando…

Proliferative Vitreoretinopathy and Genetic Profile

Detalles Bibliográficos
Autor principal:	Ghasemi Falavarjani, Khalil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ophthalmic Research Center 2013
Materias:	News
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691972/ https://www.ncbi.nlm.nih.gov/pubmed/23825722

Ejemplares similares

Retinotomy and Retinectomy in the Management of Rhegmatogenous Retinal Detachment Associated with Advanced Proliferative Vitreoretinopathy
por: Zand, Amin, et al.
Publicado: (2022)

A Highly Specific Biomarker for Early Diagnosis and Treatment of Neovascular Age-Related Macular Degeneration
por: Falavarjani, Khalil Ghasemi
Publicado: (2010)

Gene Therapy for Inherited Retinal Disorders Short Term Results of the First Human Trials in Leber’s Congenital Amaurosis
por: Ghasemi Falavarjani, Khalil
Publicado: (2009)

Implantable Posterior Segment Drug Delivery Devices; Novel Alternatives to Currently Available Treatments
por: Ghasemi Falavarjani, Khalil
Publicado: (2009)

Erythropoietin; a Novel Neuroprotective Agent for Ocular Disorders
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2011)

New Hope for Retinoblastoma Patients
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2010)

Proliferative Vitreoretinopathy: A Reappraisal
por: Carpineto, Paolo, et al.
Publicado: (2023)

The proteomic profile of a mouse model of proliferative vitreoretinopathy
por: Márkus, Bernadett, et al.
Publicado: (2017)

The impact of octreotide in experimental proliferative vitreoretinopathy
por: Evren, Ozge, et al.
Publicado: (2013)

Proliferative vitreoretinopathy: current and emerging treatments
por: Sadaka, Ama, et al.
Publicado: (2012)

Fulminant proliferative vitreoretinopathy in syphilitic uveitis
por: Queiroz, Rafael de Pinho, et al.
Publicado: (2016)

Intravitreal methotrexate infusion for proliferative vitreoretinopathy
por: Sadaka, Ama, et al.
Publicado: (2016)

Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy
por: Benner, Jeffrey David, et al.
Publicado: (2019)

Subretinal Perfluorocarbon Liquid for Dissection of Proliferative Vitreoretinopathy
por: Dalma-Weiszhausz, Jose, et al.
Publicado: (2012)

Evaluation of retinectomy in the treatment of severe proliferative vitreoretinopathy
por: Mendes, Thaís Sousa, et al.
Publicado: (2015)

Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy
por: Takkar, Brijesh, et al.
Publicado: (2017)

Biological Involvement of MicroRNAs in Proliferative Vitreoretinopathy
por: Kaneko, Hiroki, et al.
Publicado: (2017)

Inflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development
por: Chaudhary, Rishika, et al.
Publicado: (2020)

Inflammatory mediators of proliferative vitreoretinopathy: hypothesis and review
por: Dai, Ying, et al.
Publicado: (2020)

Distinct Serum and Vitreous Inflammation-Related Factor Profiles in Patients with Proliferative Vitreoretinopathy
por: Ni, Yao, et al.
Publicado: (2020)

Assessment of the innate and adaptive immune system in proliferative vitreoretinopathy
por: Zhang, W, et al.
Publicado: (2012)

Mechanisms of Inflammation in Proliferative Vitreoretinopathy: From Bench to Bedside
por: Moysidis, Stavros N., et al.
Publicado: (2012)

Aquaporin-1 Expression in Proliferative Vitreoretinopathy and in Epiretinal Membranes
por: Motulsky, Elie, et al.
Publicado: (2014)

Outcomes of Vitrectomy in Pediatric Retinal Detachment with Proliferative Vitreoretinopathy
por: Rejdak, Robert, et al.
Publicado: (2017)

Commentary: Management of proliferative vitreoretinopathy in recurrent retinal detachment
por: Babu, Naresh, et al.
Publicado: (2020)

Doxycycline Ameliorates the Severity of Experimental Proliferative Vitreoretinopathy in Mice
por: Chen, Shun-Hua, et al.
Publicado: (2021)

Infographic: Slow-release dexamethasone in proliferative vitreoretinopathy (PVR)
por: Mostafa, I., et al.
Publicado: (2021)

Proteomic Insight into the Role of Exosomes in Proliferative Vitreoretinopathy Development
por: Nair, Gopa Kumar Gopinadhan, et al.
Publicado: (2022)

The Effect of Anti-Autotaxin Aptamers on the Development of Proliferative Vitreoretinopathy
por: Hanazaki, Hirotsugu, et al.
Publicado: (2023)

Characterisation of the inflammatory cytokine and growth factor profile in a rabbit model of proliferative vitreoretinopathy
por: Wong, Chee Wai, et al.
Publicado: (2019)

Perfluorocarbon Liquid for Dissection of Proliferative Vitreoretinopathy: Avoiding Subretinal Persistence
por: Mowatt, Lizette
Publicado: (2013)

OM-101 Decreases the Fibrotic Response Associated with Proliferative Vitreoretinopathy
por: Dvashi, Zeev, et al.
Publicado: (2017)

Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy
por: Amarnani, Dhanesh, et al.
Publicado: (2017)

A sustained dual drug delivery system for proliferative vitreoretinopathy
por: Xiao, Ying, et al.
Publicado: (2020)

Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model
por: Heffer, Alison M., et al.
Publicado: (2020)

Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy
por: Datlibagi, Azine, et al.
Publicado: (2023)

Key Factors to Improve the Outcome of Retinal Reattachment Surgery in Proliferative Vitreoretinopathy and Proliferative Diabetic Retinopathy
por: Deuchler, Svenja, et al.
Publicado: (2017)

Sustained closure of surgically repaired macular hole after proliferative vitreoretinopathy
por: Mitamura, Yoshinori, et al.
Publicado: (2008)

Radial Retinotomies with Endodiathermy for Severe Proliferative Vitreoretinopathy: Short-Term Results
por: Jiang, Zhaoxin, et al.
Publicado: (2016)

Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases
por: Ma, Gaoen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_puc2oi18l9thnd0dm70v4l1keb